TheEdgeResearch
Home / Stocks / CNFHF

CanaFarma Hemp Products Corp. (CNFHF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$19,561
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-0.05
52-Wk Range
0.000001-0.0001
CEO
Phil Klauder
Country
CA
Currency
USD

CanaFarma Hemp Products Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $19,561. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -986.7%. Its beta of -0.05 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.01
Price / Book
-0.15
EV / EBITDA
0.10
Gross margin
-132.1%
Operating margin
-565.8%
Net margin
-986.7%
Return on equity
Debt / equity
0.00
Current ratio
0.77
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
5
IPO date
2021-04-01
Headquarters
Vancouver, BC, CA
About CanaFarma Hemp Products Corp.

CanaFarma Hemp Products Corp., headquartered in Vancouver, Canada, is actively involved in the cultivation, processing, and distribution of hemp oil across the United States. The company expands its offerings to include various hemp-derived consumer products, such as YOOFORIC-branded chewing gum and tinctures, all of which are accessible through its online sales channel.

Comparable companies

CanaFarma Hemp Products Corp. is most often compared with the following Healthcare names:

AUSAFAYRWFAYURFBGXXBLMHCLCFFCRRTFIONKFOILFFUNVC
More research on CNFHF
CNFHF technical analysis CNFHF TheEdge Score Compare against peers
Open full interactive analysis & DCF →